AzTrials
AzTrials

Circuit-based High Intensity Interval TrainingDoITNCT03134781

Hybrid Exercise Training for Weight Loss

A study testing DoIT workout and DoIT workout - Detraining in people with Circuit-based High Intensity Interval Training and Body Composition, run by University of Thessaly at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study the investigators utilized a novel hybrid HIIT (high intensity interval training) exercise training approach, the Hybrid Interval Training (DoIT) workout that combines interval training, resistance exercise training and functional training in order to test the hypothesis that DoIT will be able to: i)… Read more about this study

Who is it for?
Ages 30 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
DoIT workout and DoIT workout - Detraining
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
1 siteGreece
Study dates
Jul 2015to Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • (a) were sedentary (<7,500 steps/day; VO2max <30 ml/kg/min), b) premenopausal women aged 30-45 years, c) were overweight or obese class 1 (BMI=25-34.9 kg/m2), d) were non-smokers for ≥6 months before the study, e) not following a diet intervention or using nutritional supplements/medications before (≥6 months) and during the study, f) had no weight loss greater >10% of body mass ≤6 months before the study, g) participated in ≥80% of total exercise sessions, and h) had no symptoms of depression.

Who cannot join

  • a) a recent febrile illness, b) history of muscle lesion, c) lower limb trauma, d) signs, symptoms or diagnosis of serious health complications or physical disability or other medical condition compromising safe participation in exercise training.

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly

    Trikala, Karies, 42100

Other trials in Greece

About this study

Official title: The Effects of a Novel Hybrid Exercise Training Program on Body Composition, Body Weight and Energy Balance in Sedentary Overweight/Obese Women

In this study the investigators utilized a novel hybrid HIIT (high intensity interval training) exercise training approach, the Hybrid Interval Training (DoIT) workout that combines interval training, resistance exercise training and functional training in order to test the hypothesis that DoIT will be able to: i) reduce body mass, ii) improve body composition and iii) alter energy balance, of previously inactive, overweight/obese women.

Read the detailed description

In a controlled randomized, two-group, repeated measures design, 65 healthy, sedentary, premenopausal overweight or obese women were randomly assigned to one of three groups: (a) a control group (C, N=21) that participated only in measurements, (b) a training group (TR, N=14) that participated in a supervised 40-week DoIT workout exercise training program and (c) a training-detraining group (TRD, N=14). During the first 20 weeks, TR and TRD followed exactly the same training protocol. At the end of this period, TR continued training for 20 more weeks whereas TRD terminated training for 20 weeks (detraining). Anthropometric, metabolic, daily nutritional intake, habitual physical activity and performance measurements were performed in all groups at baseline, at 20 weeks and 40 weeks.

Being tested
DoIT workout, DoIT workout - Detraining, Control - No training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DoIT workoutBehavioural

    A hybrid small-group (5-10 women/session) training modality, that combines interval training, resistance exercise and functional training and performed according to a periodized model of exercise prescription as an alternative approach for weight management. FFIT was performed 3 times/week with 48 hours recovery between sessions for 40 weeks.

  • DoIT workout - DetrainingBehavioural

    A hybrid small-group (5-10 women/session) training modality, that combines interval training, resistance exercise and functional training, performed according to a periodized model of exercise prescription for a 20-week period (3 times/week). Immediately after a 20-week detraining period (no training was performed) was followed.

  • Control - No trainingBehavioural

    No training was performed during a 40-week period. Participation only in measurements.

Study groups in NCT03134781
Study groupRoleWhat they receive
ControlExperimentalParticipated only in measurements at baseline, at 20 weeks and at 40 weeks.
Receives: Behavioral: Control - No training
TrainingExperimentalParticipated in a supervised 40-week DoIT workout exercise training program and in measurements at baseline, at 20 weeks and at 40 weeks.
Receives: Behavioral: DoIT workout
Training-DetrainingExperimentalParticipated in a supervised 20-week DoIT workout exercise training program and then entered a 20-week detraining period. They also participated in measurements at baseline, at 20 weeks and at 40 weeks.
Receives: Behavioral: DoIT workout - Detraining

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in body mass

    Measured: At baseline, at 20 weeks and at 40 weeks.

  2. Change in body mass index

    Measured: At baseline, at 20 weeks and at 40 weeks.

  3. Change in waist circumference

    Measured: At baseline, at 20 weeks and at 40 weeks.

  4. Change in hip circumference

    Measured: At baseline, at 20 weeks and at 40 weeks.

  5. Change in waist-to-hip ratio

    Measured: At baseline, at 20 weeks and at 40 weeks.

  6. Change in body fat.

    Body fat assessed by whole-body dual-energy X-ray absorptiometry (DXA).

    Measured: At baseline, at 20 weeks and at 40 weeks.

  7. Change in fat mass

    Fat mass assessed by whole-body dual-energy X-ray absorptiometry (DXA).

    Measured: At baseline, at 20 weeks and at 40 weeks.

  8. Change in fat-free mass

    Fat-free mass assessed by whole-body dual-energy X-ray absorptiometry (DXA).

    Measured: At baseline, at 20 weeks and at 40 weeks.

  9. Change in resting metabolic rate

    Measured using a portable open-circuit indirect calorimeter with a ventilated hood system.

    Measured: At baseline, at 20 weeks and at 40 weeks.

  10. Change in exercise-induced caloric expenditure.

    Measured using a portable indirect calorimetry system

    Measured: At baseline, at 20 weeks and at 40 weeks.

Secondary outcomes (5)
  1. Change in maximal strength (1RM)

    Measured bilaterally on a horizontal leg press.

    Measured: At baseline, at 20 weeks and at 40 weeks.

  2. Change in maximal oxygen consumption (VO2max)

    Assessed by a portable open-circuit spirometry system.

    Measured: At baseline, at 20 weeks and at 40 weeks.

  3. Change in blood lactate concentration

    Measured: Pre-exercise, during the exercise and post-exercise at baseline, at 20 weeks and at 40 weeks.

  4. Change in habitual physical activity

    Seven-day habitual physical activity was assessed by accelerometry

    Measured: At baseline, at 20 weeks and at 40 weeks.

  5. Change in dietary intake

    Assessed using 7-day diet recalls

    Measured: At baseline, at 20 weeks and at 40 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2017
  2. Study startJul 2015
  3. Primary completionJul 2016
  4. Study completionApr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03134781
Sponsor's protocol ID
DoIT-UTH
Acronym
DoIT
Status last verified
Oct 2021
First submitted
26 Apr 2017
Last updated
28 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Batrakoulis A, Jamurtas AZ, Georgakouli K, Draganidis D, Deli CK, Papanikolaou K, Avloniti A, Chatzinikolaou A, Leontsini D, Tsimeas P, Comoutos N, Bouglas V, Michalopoulou M, Fatouros IG. High intensity, circuit-type integrated neuromuscular training alters energy balance and reduces body mass and fat in obese women: A 10-month training-detraining randomized controlled trial. PLoS One. 2018 Aug 23;13(8):e0202390. doi: 10.1371/journal.pone.0202390. eCollection 2018.

    PubMed 30138475
  • Batrakoulis A, Loules G, Georgakouli K, Tsimeas P, Draganidis D, Chatzinikolaou A, Papanikolaou K, Deli CK, Syrou N, Comoutos N, Theodorakis Y, Jamurtas AZ, Fatouros IG. High-intensity interval neuromuscular training promotes exercise behavioral regulation, adherence and weight loss in inactive obese women. Eur J Sport Sci. 2020 Jul;20(6):783-792. doi: 10.1080/17461391.2019.1663270. Epub 2019 Sep 16.

    PubMed 31478436
  • Batrakoulis A, Tsimeas P, Deli CK, Vlachopoulos D, Ubago-Guisado E, Poulios A, Chatzinikolaou A, Draganidis D, Papanikolaou K, Georgakouli K, Batsilas D, Gracia-Marco L, Jamurtas AZ, Fatouros I. Hybrid neuromuscular training promotes musculoskeletal adaptations in inactive overweight and obese women: A training-detraining randomized controlled trial. J Sports Sci. 2021 Mar;39(5):503-512. doi: 10.1080/02640414.2020.1830543. Epub 2020 Oct 15.

    PubMed 33054601
  • Batrakoulis A, Jamurtas AZ, Draganidis D, Georgakouli K, Tsimeas P, Poulios A, Syrou N, Deli CK, Papanikolaou K, Tournis S, Fatouros IG. Hybrid Neuromuscular Training Improves Cardiometabolic Health and Alters Redox Status in Inactive Overweight and Obese Women: A Randomized Controlled Trial. Antioxidants (Basel). 2021 Oct 12;10(10):1601. doi: 10.3390/antiox10101601.

    PubMed 34679738
  • 2020 NSCA Research Abstracts. J Strength Cond Res. 2021 Apr 1;35(4):e3-e288. doi: 10.1519/JSC.0000000000003877. No abstract available.

    PubMed 33752224

Questions about this trial

What is this clinical trial studying?

A study testing DoIT workout and DoIT workout - Detraining in people with Circuit-based High Intensity Interval Training and Body Composition, run by University of Thessaly at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in body mass (time frame: At baseline, at 20 weeks and at 40 weeks.). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03134781, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2021; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in